Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
Part of paid clinical trials in Phoenix, Arizona.
- Sponsor
- Clearside Biomedical, Inc.
- Study ID
- NCT02303184
- Phase
- PHASE2
- Status
- Completed
Conditions
- Macular Edema
- Retinal Vein Occlusion
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 4 mg CLS-TA — DRUG40 mg/mL CLS-TA, Clearside's formulation of TA (CLS-TA, triamcinolone acetonide injectable suspension)
- Sham — DRUGsuprachoroidal sham procedure
- IVT aflibercept — DRUG2 mg intravitreal injection of aflibercept
Study Details
A phase 2, multicenter, randomized, active-controlled, masked, parallel arm study designed to evaluate the safety and efficacy of a single suprachoroidal injection of CLS-TA, triamcinolone acetonide injectable suspension, given along with an intravitreal (IVT) injection of aflibercept compared to IVT aflibercept alone in subjects with retinal vein occlusion (RVO).
Key Dates
- Start date
- Jan 31, 2015
- Status verified
- Jan 2021
- Primary completion
- Mar 31, 2016
- Completion
- Mar 31, 2016
Study Design
- Enrollment
- 46 participants (actual)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: 4 mg CLS-TA + IVT afliberceptSingle unilateral, suprachoroidal injection of 40 mg/mL (4 mg in 100 µL) of CLS-TA following a 2 mg intravitreal injection of aflibercept
- Active Comparator: sham + IVT afliberceptSingle unilateral, suprachoroidal sham procedure following a 2 mg intravitreal injection of aflibercept
Primary Outcome Measure
Total Number of Times a Subject Qualifies to be Administered IVT Aflibercept in Each Arm [ Time Frame: 3 months ]
Locations (14)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| - | Phoenix | Arizona | 85014 | - |
| - | Beverly Hills | California | 90211 | - |
| - | San Diego | California | 92037 | - |
| - | Boynton Beach | Florida | 33426 | - |
| - | Atlanta | Georgia | 30322 | - |
| - | Baltimore | Maryland | 21287 | - |
| - | St Louis | Missouri | 63128 | - |
| - | Winston-Salem | North Carolina | 27157 | - |
| - | Rapid City | South Dakota | 57701 | - |
| - | Abilene | Texas | 79606 | - |
| - | Houston | Texas | 77030 | - |
| - | McAllen | Texas | 78503 | - |
| - | San Antonio | Texas | 78251 | - |
| - | The Woodlands | Texas | 77384 | - |
Related Studies
- National Eye Institute Biorepository for Retinal DiseasesRecruiting · National Eye Institute (NEI) · Bethesda, Maryland
- Optical Coherence Tomography Angiography in Subjects With Retinal Vascular DiseaseRecruiting · Johns Hopkins University · Baltimore, Maryland
- A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic Macular EdemaPHASE2 · Recruiting · Boehringer Ingelheim · Arcadia, California
- Study Evaluating the Efficacy and Safety of Chloroprocaine HCl Ophthalmic Gel 3% vs Proparacaine Ophthalmic Solution 0.5% Plus Subconjunctival Lidocaine in Patients Undergoing Intravitreal InjectionsPHASE4 · Enrolling By Invitation · Harrow Inc · Tyler, Texas